MELANIE COBB: Open Payments
NPI 1982944922 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 27 payments from 10 companies in 2025. Trend: 2023 $244 · 2024 $352 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 10 | $358 |
| Galderma Laboratories, L.P. | 2 | $177 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $130 |
| Ferring Pharmaceuticals Inc. | 3 | $80 |
| Smith+Nephew, Inc. | 1 | $30 |
| Cumberland Pharmaceuticals, Inc. | 2 | $29 |
| Ethicon US, LLC | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $15 |
Products named: Xeomin, JOURNAVX, EUFLEXXA, STRAVIX, CALDOLOR, VISTASEAL, Iovera, ZYNRELEF.
Industry payments across TX — which companies pay providers there.
